Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 430

1.

β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease.

Mori K, Naganuma M, Mizuno S, Suzuki H, Kitazume MT, Shimamura K, Chiba S, Sugita A, Matsuoka K, Hisamatsu T, Kanai T.

Intest Res. 2018 Jul;16(3):384-392. doi: 10.5217/ir.2018.16.3.384. Epub 2018 Jul 27.

2.

MAP1981c, a Putative Nucleic Acid-Binding Protein, Produced by Mycobacterium avium subsp. paratuberculosis, Induces Maturation of Dendritic Cells and Th1-Polarization.

Kim WS, Shin MK, Shin SJ.

Front Cell Infect Microbiol. 2018 Jun 21;8:206. doi: 10.3389/fcimb.2018.00206. eCollection 2018.

3.

Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype.

Lord JD, Long SA, Shows DM, Thorpe J, Schwedhelm K, Chen J, Kita M, Buckner JH.

Clin Immunol. 2018 Aug;193:24-32. doi: 10.1016/j.clim.2018.05.006. Epub 2018 May 26.

4.

Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis.

Parisinos CA, Serghiou S, Katsoulis M, George MJ, Patel RS, Hemingway H, Hingorani AD.

Gastroenterology. 2018 Aug;155(2):303-306.e2. doi: 10.1053/j.gastro.2018.05.022. Epub 2018 Jul 5.

5.

Fecal bacteria from Crohn's disease patients more potently activated NOD-like receptors and Toll-like receptors in macrophages, in an IL-4-repressible fashion.

Gu J, Liu G, Xing J, Song H, Wang Z.

Microb Pathog. 2018 Aug;121:40-44. doi: 10.1016/j.micpath.2018.05.009. Epub 2018 May 9.

PMID:
29752990
6.

Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.

Lian L, Huang Q, Zhang L, Qin H, He X, He X, Ke J, Xie M, Lan P.

Dig Dis Sci. 2018 Jul;63(7):1821-1834. doi: 10.1007/s10620-018-5082-8. Epub 2018 Apr 27.

PMID:
29704139
7.

Immunotherapy in inflammatory bowel disease: Novel and emerging treatments.

Catalan-Serra I, Brenna Ø.

Hum Vaccin Immunother. 2018 Apr 6:1-15. doi: 10.1080/21645515.2018.1461297. [Epub ahead of print]

PMID:
29624476
8.

IL-6, IL-1β, and TNF-α only in combination influence the osteoporotic phenotype in Crohn's patients via bone formation and bone resorption.

Blaschke M, Koepp R, Cortis J, Komrakova M, Schieker M, Hempel U, Siggelkow H.

Adv Clin Exp Med. 2018 Jan;27(1):45-56. doi: 10.17219/acem/67561.

9.

T300A variant of AT16L1 gene in a cohort of Algerian Crohn disease patients.

Aida I, Meddour Y, Kadiri H, Smara M, Bousseloub A, Kecili L, Gamar L, Belhocine K, Boussafsaf MA, Debzi N, Aouichat-Bouguerra S, Chaib S.

Curr Res Transl Med. 2018 Mar;66(1):9-14. doi: 10.1016/j.retram.2018.01.002. Epub 2018 Mar 5.

PMID:
29519712
10.

Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines.

Bourgonje AR, von Martels JZH, de Vos P, Faber KN, Dijkstra G.

PLoS One. 2018 Feb 21;13(2):e0193202. doi: 10.1371/journal.pone.0193202. eCollection 2018.

11.

Pediatric Crohn disease is characterized by Th1 in the terminal ileum and Th1/Th17 immune response in the colon.

Savić Mlakar A, Hojsak I, Jergović M, Čimić S, Bendelja K.

Eur J Pediatr. 2018 Apr;177(4):611-616. doi: 10.1007/s00431-017-3076-8. Epub 2018 Feb 3.

PMID:
29397417
12.

Clinical Significance of Bmi1 Expression in Inflammatory Bowel Disease.

Yamada M, Sakurai T, Komeda Y, Nagai T, Kamata K, Minaga K, Yamao K, Takenaka M, Hagiwara S, Matsui S, Watanabe T, Nishida N, Kashida H, Kudo M.

Oncology. 2017;93 Suppl 1:20-26. doi: 10.1159/000481225. Epub 2017 Dec 20.

13.

Associations between inflammatory bowel diseases and vitamin D.

Barbalho SM, Goulart RA, Gasparini RG.

Crit Rev Food Sci Nutr. 2017 Dec 13:1-10. doi: 10.1080/10408398.2017.1406333. [Epub ahead of print]

PMID:
29236523
14.

The different roles of innate immune receptors in inflammation and carcinogenesis between races.

Yamaguchi N, Suzuki Y, Mahbub MH, Takahashi H, Hase R, Ishimaru Y, Sunagawa H, Watanabe R, Eishi Y, Tanabe T.

Environ Health Prev Med. 2017 Oct 11;22(1):70. doi: 10.1186/s12199-017-0678-8.

15.

Correlation between intestinal flora and serum inflammatory factors in patients with Crohn's disease.

Zhang J, Chen SL, Li LB.

Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4913-4917.

16.

Combined use of high doses of vasopressin and corticosteroids in a patient with Crohn's disease with refractory septic shock after intestinal perforation: a case report.

Notaro S, Sorrentino M, Ruocco A, Notaro A, Corcione A, Murino P, Piscitelli E, Tamborino M.

J Med Case Rep. 2017 Nov 13;11(1):320. doi: 10.1186/s13256-017-1456-3.

17.

Expression of REG family genes in human inflammatory bowel diseases and its regulation.

Tsuchida C, Sakuramoto-Tsuchida S, Taked M, Itaya-Hironaka A, Yamauchi A, Misu M, Shobatake R, Uchiyama T, Makino M, Pujol-Autonell I, Vives-Pi M, Ohbayashi C, Takasawa S.

Biochem Biophys Rep. 2017 Oct 23;12:198-205. doi: 10.1016/j.bbrep.2017.10.003. eCollection 2017 Dec.

18.

Serum Hepcidin in Children with Inflammatory Bowel Disease.

Krawiec P, Mroczkowska-Juchkiewicz A, Pac-Kożuchowska E.

Inflamm Bowel Dis. 2017 Dec;23(12):2165-2171. doi: 10.1097/MIB.0000000000001245.

PMID:
28945637
19.

Expression of Interleukin-26 is upregulated in inflammatory bowel disease.

Fujii M, Nishida A, Imaeda H, Ohno M, Nishino K, Sakai S, Inatomi O, Bamba S, Kawahara M, Shimizu T, Andoh A.

World J Gastroenterol. 2017 Aug 14;23(30):5519-5529. doi: 10.3748/wjg.v23.i30.5519.

20.

Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells.

Takahashi Y, Sato S, Kurashima Y, Lai CY, Otsu M, Hayashi M, Yamaguchi T, Kiyono H.

EBioMedicine. 2017 Sep;23:34-45. doi: 10.1016/j.ebiom.2017.07.027. Epub 2017 Aug 2.

Supplemental Content

Loading ...
Support Center